位置:首页 > 蛋白库 > HTMR_MYCTU
HTMR_MYCTU
ID   HTMR_MYCTU              Reviewed;         139 AA.
AC   P9WME9; L0TCJ1; P67747; Q10810;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   03-AUG-2022, entry version 42.
DE   RecName: Full=HTH-type transcriptional repressor Rv2887 {ECO:0000305};
GN   OrderedLocusNames=Rv2887; ORFNames=MTCY274.18;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=H37Rv;
RX   PubMed=26303802; DOI=10.1128/aac.01341-15;
RA   Winglee K., Lun S., Pieroni M., Kozikowski A., Bishai W.;
RT   "Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis
RT   resistance to an imidazopyridine-based agent.";
RL   Antimicrob. Agents Chemother. 59:6873-6881(2015).
RN   [4]
RP   FUNCTION, DNA-BINDING, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF ARG-81.
RC   STRAIN=H37Rv;
RX   PubMed=27432954; DOI=10.1073/pnas.1606590113;
RA   Warrier T., Kapilashrami K., Argyrou A., Ioerger T.R., Little D.,
RA   Murphy K.C., Nandakumar M., Park S., Gold B., Mi J., Zhang T., Meiler E.,
RA   Rees M., Somersan-Karakaya S., Porras-De Francisco E., Martinez-Hoyos M.,
RA   Burns-Huang K., Roberts J., Ling Y., Rhee K.Y., Mendoza-Losana A., Luo M.,
RA   Nathan C.F.;
RT   "N-methylation of a bactericidal compound as a resistance mechanism in
RT   Mycobacterium tuberculosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E4523-E4530(2016).
RN   [5] {ECO:0007744|PDB:5HSM, ECO:0007744|PDB:5HSO, ECO:0007744|PDB:5X7Z, ECO:0007744|PDB:5X80}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF APOPROTEIN AND IN COMPLEXES WITH
RP   DNA; P-AMINOSALICYLIC ACID AND SALICYLIC ACID, FUNCTION, ACTIVITY
RP   REGULATION, SUBUNIT, DOMAIN, AND MUTAGENESIS OF ARG-42 AND ASP-114.
RC   STRAIN=H37Rv;
RX   PubMed=28743871; DOI=10.1038/s41598-017-01705-4;
RA   Gao Y.R., Li D.F., Fleming J., Zhou Y.F., Liu Y., Deng J.Y., Zhou L.,
RA   Zhou J., Zhu G.F., Zhang X.E., Wang D.C., Bi L.J.;
RT   "Structural analysis of the regulatory mechanism of MarR protein Rv2887 in
RT   M. tuberculosis.";
RL   Sci. Rep. 7:6471-6471(2017).
CC   -!- FUNCTION: Represses expression of the HQNO methyltransferase htm gene
CC       (Rv0560c) by binding to its promoter region (PubMed:26303802,
CC       PubMed:27432954, PubMed:28743871). Also represses the expression of at
CC       least five other genes, including the methyltransferase Rv0558
CC       (PubMed:26303802). Binds salicylate (SA), para-aminosalicylic acid
CC       (PAS) and gemfibrozil (PubMed:28743871). {ECO:0000269|PubMed:26303802,
CC       ECO:0000269|PubMed:27432954, ECO:0000269|PubMed:28743871}.
CC   -!- ACTIVITY REGULATION: Binding of effector molecule SA, or its structural
CC       analog PAS, to the binding pocket of Rv2887 induces conformational
CC       change in its DNA binding domain, preventing binding to the promoter
CC       region of htm, triggering the expression of this SAM-dependent
CC       methyltransferase. {ECO:0000269|PubMed:28743871}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:28743871}.
CC   -!- DOMAIN: Conformational changes take place in the N-terminal and the
CC       winged-HTH (wHTH) domain on ligand or DNA binding. SA and PAS stabilize
CC       a conformation of Rv2887 incompatible with DNA binding. Rotation of the
CC       N-terminal plays a key role in the dimerization.
CC       {ECO:0000269|PubMed:28743871}.
CC   -!- DISRUPTION PHENOTYPE: Mutation of the gene leads to derepression and
CC       increased expression of htm (PubMed:27432954). Inactivation of the gene
CC       confers resistance to the imidazo[1,2-a]pyridine-4-carbonitrile-based
CC       agent MP-III-71, an effective antimycobacterial compound that shows no
CC       cross-resistance to existing antituberculosis drugs (PubMed:26303802).
CC       {ECO:0000269|PubMed:26303802, ECO:0000269|PubMed:27432954}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP45689.1; -; Genomic_DNA.
DR   PIR; B70925; B70925.
DR   RefSeq; NP_217403.1; NC_000962.3.
DR   RefSeq; WP_003899525.1; NZ_NVQJ01000006.1.
DR   PDB; 5HSM; X-ray; 1.90 A; A=1-139.
DR   PDB; 5HSO; X-ray; 2.50 A; A/B/C/D=1-139.
DR   PDB; 5X7Z; X-ray; 2.20 A; A=1-139.
DR   PDB; 5X80; X-ray; 2.40 A; A/B/C/D=1-139.
DR   PDBsum; 5HSM; -.
DR   PDBsum; 5HSO; -.
DR   PDBsum; 5X7Z; -.
DR   PDBsum; 5X80; -.
DR   AlphaFoldDB; P9WME9; -.
DR   SMR; P9WME9; -.
DR   STRING; 83332.Rv2887; -.
DR   PaxDb; P9WME9; -.
DR   DNASU; 888563; -.
DR   GeneID; 45426875; -.
DR   GeneID; 888563; -.
DR   KEGG; mtu:Rv2887; -.
DR   TubercuList; Rv2887; -.
DR   eggNOG; COG1846; Bacteria.
DR   OMA; EFVCLRI; -.
DR   PhylomeDB; P9WME9; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR000835; HTH_MarR-typ.
DR   InterPro; IPR023187; Tscrpt_reg_MarR-type_CS.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF01047; MarR; 1.
DR   PRINTS; PR00598; HTHMARR.
DR   SMART; SM00347; HTH_MARR; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS01117; HTH_MARR_1; 1.
DR   PROSITE; PS50995; HTH_MARR_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-binding; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..139
FT                   /note="HTH-type transcriptional repressor Rv2887"
FT                   /id="PRO_0000054410"
FT   DOMAIN          6..138
FT                   /note="HTH marR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00345"
FT   BINDING         42
FT                   /ligand="salicylate"
FT                   /ligand_id="ChEBI:CHEBI:30762"
FT                   /evidence="ECO:0000269|PubMed:28743871"
FT   BINDING         114
FT                   /ligand="salicylate"
FT                   /ligand_id="ChEBI:CHEBI:30762"
FT                   /evidence="ECO:0000269|PubMed:28743871"
FT   MUTAGEN         42
FT                   /note="R->A: Attenuates the ability to bind salicylate."
FT                   /evidence="ECO:0000269|PubMed:28743871"
FT   MUTAGEN         81
FT                   /note="R->Q: Abolishes binding to Rv0560c promoter."
FT                   /evidence="ECO:0000269|PubMed:27432954"
FT   MUTAGEN         114
FT                   /note="D->A: Attenuates the ability to bind salicylate."
FT                   /evidence="ECO:0000269|PubMed:28743871"
FT   TURN            2..4
FT                   /evidence="ECO:0007829|PDB:5HSM"
FT   HELIX           8..28
FT                   /evidence="ECO:0007829|PDB:5HSM"
FT   HELIX           29..31
FT                   /evidence="ECO:0007829|PDB:5HSM"
FT   HELIX           35..46
FT                   /evidence="ECO:0007829|PDB:5HSM"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:5X7Z"
FT   HELIX           52..58
FT                   /evidence="ECO:0007829|PDB:5HSM"
FT   HELIX           63..75
FT                   /evidence="ECO:0007829|PDB:5HSM"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:5X7Z"
FT   STRAND          85..88
FT                   /evidence="ECO:0007829|PDB:5X80"
FT   HELIX           97..118
FT                   /evidence="ECO:0007829|PDB:5HSM"
FT   HELIX           123..136
FT                   /evidence="ECO:0007829|PDB:5HSM"
SQ   SEQUENCE   139 AA;  14690 MW;  EB775A4CC03A24C0 CRC64;
     MGLADDAPLG YLLYRVGAVL RPEVSAALSP LGLTLPEFVC LRMLSQSPGL SSAELARHAS
     VTPQAMNTVL RKLEDAGAVA RPASVSSGRS LPATLTARGR ALAKRAEAVV RAADARVLAR
     LTAPQQREFK RMLEKLGSD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024